1. Home
  2. MHK vs IBRX Comparison

MHK vs IBRX Comparison

Compare MHK & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mohawk Industries Inc.

MHK

Mohawk Industries Inc.

HOLD

Current Price

$107.52

Market Cap

6.2B

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.79

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHK
IBRX
Founded
1988
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
7.2B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
MHK
IBRX
Price
$107.52
$7.79
Analyst Decision
Buy
Strong Buy
Analyst Count
11
7
Target Price
$126.10
$12.57
AVG Volume (30 Days)
735.1K
12.5M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.71
EPS
1.90
N/A
Revenue
N/A
$113,288,000.00
Revenue This Year
$3.38
$88.59
Revenue Next Year
$3.09
$131.15
P/E Ratio
$57.89
N/A
Revenue Growth
N/A
668.31
52 Week Low
$92.99
$1.95
52 Week High
$143.13
$12.43

Technical Indicators

Market Signals
Indicator
MHK
IBRX
Relative Strength Index (RSI) 44.37 45.47
Support Level $104.49 $7.77
Resistance Level $107.98 $8.54
Average True Range (ATR) 4.39 0.67
MACD -1.45 -0.03
Stochastic Oscillator 8.20 30.38

Price Performance

Historical Comparison
MHK
IBRX

About MHK Mohawk Industries Inc.

Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Global Ceramic designs, manufactures, sources, distributes and markets a broad line of ceramic, porcelain and natural stone tile products used for floor and wall applications in residential and commercial channels for both remodeling and new construction. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: